Luis Marti-Bonmati | |
---|---|
Born | December 30, 1959 |
Alma mater | |
Scientific career | |
Institutions | La Fe Polytechnic and University Hospital |
Thesis | Magnetic Resonance Imaging of Liver Tumours (1991) |
Website |
Luis Marti-Bonmati is a Spanish professor and researcher.[1] He is the director of the Clinical Area of Medical Imaging Department at La Fe Polytechnic and University Hospital ,[2] and Head of Radiology Department at QuironSalud Hospital, Valencia, Spain.[3] Marti-Bonmati is the founder of QUIBIM S.L., and is the Director of its Scientific Advisory Board.[4] He is a member of the Spanish National Royal Academy of Medicine .[5] He is also the director of the Biomedical Imaging Research Group (GIBI230) at La Fe Health Research Institute.[2] The group is now included in the Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia, Spain.
He did his undergraduate medical training at the University of Valencia. He completed his postgraduate training as a resident in radiology. He obtained his doctoral thesis (Ph.D.) from the University of Valencia in 1990 with a thesis on magnetic resonance (MR) imaging in liver tumors.[1]
He joined the radiology department at the first university hospital with an MR system in Spain in 1987.[6] He became the section chief in Magnetic Resonance imaging in this Radiology department (1995) and became professor of radiology at the University of Valencia (2011).
Marti-Bonmati was appointed as President of the Sociedad Española de Diagnóstico por Imagen del Abdomen (SEDIA) in 2000 for seven years. He also served as the President of the European Society of Magnetic Resonance in Medicine and Biology from 2002 to 2004.[7] For two years starting from 2008, he was appointed as the President of the Sociedad Española de Radiología (SERAM). From 2013 to 2015, he served as the President of the European Society of Gastrointestinal and Abdominal Radiology.[1]
He is also a part of the executive council and has served as director of the Research Committee of the European Society of Radiology (ESR, 2010–2013).[8] Marti-Bonmati also serves as the director of Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia, Spain.[9]
Since January 2023, he has been the Scientific Director of the EUropean Federation for CAncer IMages project (EUCAIM) (proposal nº101100633).[10] EUCAIM is a pan-European digital federated infrastructure of FAIR, de-identified cancer medical images coming from Real-World data. The infrastructure is an experimentation platform to facilitate the development and benchmarking of AI-based cancer management tools towards precision medicine in cancer diagnosis and treatment.[11]
In 2023 he set up IMAGING, a medical imaging company.[12]
Marti-Bonmati's research interests include liver MR[13] and CT, abdominal[14] and pelvic MRI, contrast agents,[15] image processing, and imaging biomarkers.[8][16] He also worked in the evaluation of liver segmentation,[17] the quantification of emphysema and pulmonary vascularization, joint cartilage thickness,[18] schizophrenia, and the microstructure, rigidity, and fragility of the trabecular bone.[19]
His group is involved in providing medical imaging AI solutions as part of cancer management.[citation needed][20] They are working on image repositories, data harmonization, radiomics, deep features, interoperability, digital twins, in silico emulated trials, open source approaches and image preparation.
Acronym | Title | Principal Investigator (IP) | Programme | Funding Entity | Grant agreement ID | Project Award Date | Project End Date |
---|---|---|---|---|---|---|---|
PRIMAGE | PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers | José Antonio Salinas Sanz | HORIZONTE 2020 (H2020) | European Commission | 826494 | 01/12/2018 | 31/05/2023 |
CHAIMELEON | Accelerating the lab to market transition of AI tools for cancer management | Luis Martí-Bonmatí | HORIZONTE 2020 (H2020) | European Commission | 952172 | 01/09/2020 | 31/02/2024 |
EUCAIM | European Federation for Cancer Images | Luis Martí-Bonmatí | Europa Digital (DIGITAL) | European Commission | 101100633 | 01/01/2023 | 31/12/2026 |
Acronym | Title | Principal Investigator (IP) | Programme | Funding Entity | Grant agreement ID | Project Award Date | Project End Date |
---|---|---|---|---|---|---|---|
PerproGlio | Integrative Personal Omics Profiles in Glioblastoma Recurrence and Therapy Resistance | Luis Martí-Bonmatí | JOINT TRANSNATIONAL CALL FOR PROPOSALS | European Commission / ISCIII | ERAPERMED2018-270 | 01/07/2019 | 30/06/2022 |
ProCancer-I | An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum | Luis Martí-Bonmatí | HORIZONTE 2020 (H2020) | European Commission | 952159 | 01/10/2020 | 30/09/2024 |
RADIOVAL | International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning | Luis Martí-Bonmatí | HORIZON EUROPE | European Commission | 101057699 | 01/09/2022 | 31/08/2026 |
CanSERV | Providing cutting edge cancer research services across Europe | Luis Martí-Bonmatí | HORIZON EUROPE | European Commission | 101058620 | 01/09/2022 | 31/08/2025 |
IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance | Bernardo Valdivieso Martínez | HORIZON EUROPE | European Commission | 101112135 | 01/04/2023 | 31/03/2028 |
NextMRI | Truly portable MRI for extremity and brain imaging anywhere & everywhere | Luis Martí-Bonmatí | HORIZON EUROPE | European Commission | 101136407 | 01/10/2023 | 30/09/2026 |
LEOPARD | Liver Electronic Offering Platform with Artificial intelligence-based Devices | Luis Martí-Bonmatí | HORIZON EUROPE | European Commission | 101080964-2 | 2023 | 2027 |
PREDICTOM | Prediction of alzheimer´s disease using an AI driven screening platform | Miguel Baquero Toledo | HORIZON EUROPE | European Commission | 101132356 | 2023 | 2028 |
Martí-Bonmatí has also published several books.